The dramatic growth in the use of biologics across multiple therapeutic applications and categories will only continue to increase. As the demand for these drugs accelerates, there are growing concerns about their cost and availability. Nandu Deorkar and Claudia Berron at Avantor highlight the key challenges and potential solutions for optimising downstream bioprocessing production.
[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2020/12/Key-Challenges-and-Potential-Solutions-for-Optimising.pdf” width=”100%” height=”900px” style=”border:0;”]
